Subtopic Deep Dive
Merkel Cell Polyomavirus
Research Guide
What is Merkel Cell Polyomavirus?
Merkel cell polyomavirus (MCV) is a human polyomavirus clonally integrated in approximately 80% of Merkel cell carcinomas (MCCs), driving oncogenesis through expression of mutated large T antigen.
MCV was discovered in MCC tumors using digital transcriptome subtraction (Feng et al., 2008, 3152 citations). Tumor-specific T antigen mutations distinguish MCV in cancer from wild-type virus in healthy skin (Shuda et al., 2008, 721 citations). Seroepidemiology shows high MCV seroprevalence in adults (Kean et al., 2009, 717 citations).
Why It Matters
MCV integration reclassifies MCC as a virus-driven cancer, enabling immunotherapy targeting PD-L1 expressed in virus-positive tumors (Lipson et al., 2013). This guides checkpoint inhibitor use, with durable responses in advanced MCC (Schadendorf et al., 2016). Viral T antigen dependency in MCC cells supports antiviral therapy development (Houben et al., 2010). Exome sequencing reveals low mutation burden in MCV-positive MCCs versus UV-driven MCV-negative cases (Goh et al., 2015).
Key Research Challenges
Viral Integration Mechanisms
Clonal MCV integration into host genome occurs early in MCC oncogenesis, but exact integration sites and host factors remain unclear (Feng et al., 2008). Sequencing studies map integrations, yet functional impacts on nearby genes are understudied.
T Antigen Oncogenic Function
Mutated large T antigen drives cell transformation, but specific pathways beyond Rb binding need elucidation (Shuda et al., 2008). Knockdown experiments confirm T antigen requirement for MCC survival (Houben et al., 2010).
Virus-Positive vs Negative MCC
MCV-negative MCCs show high UV mutation loads unlike low-burden virus-positive tumors (Goh et al., 2015). Distinguishing therapeutic responses between subtypes challenges prognosis (Schadendorf et al., 2016).
Essential Papers
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Huichen Feng, Masahiro Shuda, Yuan Chang et al. · 2008 · Science · 3.2K citations
Merkel cell carcinoma (MCC) is a rare but aggressive human skin cancer that typically affects elderly and immunosuppressed individuals, a feature suggestive of an infectious origin. We studied MCC ...
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Masahiro Shuda, Huichen Feng, Hyun Jin Kwun et al. · 2008 · Proceedings of the National Academy of Sciences · 721 citations
Merkel cell polyomavirus (MCV) is a virus discovered in our laboratory at the University of Pittsburgh that is monoclonally integrated into the genome of ≈80% of human Merkel cell carcinomas (MCCs)...
Seroepidemiology of Human Polyomaviruses
Jaime M. Kean, Suchitra Rao, Michael Wang et al. · 2009 · PLoS Pathogens · 717 citations
In addition to the previously characterized viruses BK and JC, three new human polyomaviruses (Pys) have been recently identified: KIV, WUV, and Merkel Cell Py (MCV). Using an ELISA employing recom...
Discovery of a New Human Polyomavirus Associated with Trichodysplasia Spinulosa in an Immunocompromized Patient
Els van der Meijden, René Janssens, Chris Lauber et al. · 2010 · PLoS Pathogens · 472 citations
The Polyomaviridae constitute a family of small DNA viruses infecting a variety of hosts. In humans, polyomaviruses can cause infections of the central nervous system, urinary tract, skin, and poss...
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Roland Houben, Masahiro Shuda, Rita Weinkam et al. · 2010 · Journal of Virology · 447 citations
ABSTRACT Merkel cell carcinoma (MCC) is the most aggressive skin cancer. Recently, it was demonstrated that human Merkel cell polyomavirus (MCV) is clonally integrated in ∼80% of MCC tumors. Howeve...
Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy
Tatiana Plavina, Meena Subramanyam, Gary Bloomgren et al. · 2014 · Annals of Neurology · 426 citations
Objective The increased risk of progressive multifocal leukoencephalopathy (PML) with natalizumab treatment is associated with the presence of anti–JC virus (JCV) antibodies. We analyzed whether an...
Human Skin Microbiota: High Diversity of DNA Viruses Identified on the Human Skin by High Throughput Sequencing
Vincent Foulongne, Virginie Sauvage, Charles Hébert et al. · 2012 · PLoS ONE · 383 citations
The human skin is a complex ecosystem that hosts a heterogeneous flora. Until recently, the diversity of the cutaneous microbiota was mainly investigated for bacteria through culture based assays s...
Reading Guide
Foundational Papers
Read Feng et al. (2008) first for MCV discovery and integration (3152 citations), then Shuda et al. (2008) for T antigen mutations, followed by Houben et al. (2010) for functional proof.
Recent Advances
Study Goh et al. (2015) for mutational landscapes and Lipson et al. (2013) for PD-L1 immunotherapy links; Schadendorf et al. (2016) reviews epidemiology.
Core Methods
Digital transcriptome subtraction (Feng et al., 2008), exome sequencing (Goh et al., 2015), VP1 ELISA serology (Kean et al., 2009), shRNA knockdown (Houben et al., 2010).
How PapersFlow Helps You Research Merkel Cell Polyomavirus
Discover & Search
Research Agent uses searchPapers for 'Merkel cell polyomavirus T antigen mutations' retrieving Feng et al. (2008), then citationGraph maps 3152 citing papers to track integration studies, and findSimilarPapers expands to Shuda et al. (2008). exaSearch queries seroepidemiology like Kean et al. (2009).
Analyze & Verify
Analysis Agent applies readPaperContent to extract T antigen mutation data from Shuda et al. (2008), verifies claims with CoVe against Houben et al. (2010), and runs PythonAnalysis on mutation frequencies from Goh et al. (2015) exomes using pandas for statistical comparison of MCV-positive vs negative MCC burdens with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in T antigen signaling pathways across papers, flags contradictions between MCV-positive low-mutation MCCs (Goh et al., 2015) and seroprevalence (Kean et al., 2009); Writing Agent uses latexEditText for review drafting, latexSyncCitations for 10+ papers, latexCompile for figures, and exportMermaid for oncogenic pathway diagrams.
Use Cases
"Compare mutation burdens in MCV-positive vs MCV-negative MCC"
Research Agent → searchPapers + findSimilarPapers (Goh et al., 2015) → Analysis Agent → readPaperContent + runPythonAnalysis (pandas stats on exome data) → CSV export of burden differences.
"Draft LaTeX review on MCV integration in MCC"
Synthesis Agent → gap detection (Feng et al., 2008 gaps) → Writing Agent → latexEditText + latexSyncCitations (15 papers) + latexCompile → PDF with T antigen figure.
"Find code for MCV genomic integration analysis"
Research Agent → paperExtractUrls (Feng et al., 2008) → Code Discovery → paperFindGithubRepo + githubRepoInspect → Python scripts for transcriptome subtraction.
Automated Workflows
Deep Research workflow scans 50+ MCV papers via citationGraph from Feng et al. (2008), producing structured report on integration mechanisms with GRADE grades. DeepScan applies 7-step CoVe to verify T antigen claims across Shuda et al. (2008) and Houben et al. (2010). Theorizer generates hypotheses on PD-L1 upregulation in MCV-MCC from Lipson et al. (2013).
Frequently Asked Questions
What defines Merkel cell polyomavirus?
MCV is a polyomavirus with clonal DNA integration in 80% of MCC tumors, expressing mutated T antigens (Feng et al., 2008).
What methods detect MCV in MCC?
Digital transcriptome subtraction identifies MCV sequences; immunohistochemistry confirms T antigen; PCR maps integrations (Feng et al., 2008; Shuda et al., 2008).
What are key MCV papers?
Feng et al. (2008, 3152 citations) discovered integration; Shuda et al. (2008, 721 citations) defined T mutations; Houben et al. (2010) proved oncoprotein necessity.
What are open problems in MCV research?
Integration site selection mechanisms, T antigen signaling details, and differential therapies for MCV-positive vs negative MCC remain unresolved (Goh et al., 2015).
Research Polyomavirus and related diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Merkel Cell Polyomavirus with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Polyomavirus and related diseases Research Guide